Harvard Bioscience (HBIO) Other Working Capital Changes (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Other Working Capital Changes of $139000.0 for Q1 2026, up 243.3% year-over-year from $40489.5 in Q1 2025, and down 70.92% quarter-over-quarter from $478000.0 in Q4 2025.
Harvard Bioscience (HBIO) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Other Working Capital Changes for 9 consecutive years, with $139000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 243.3% year-over-year to $139000.0; the TTM figure through Mar 2026 stood at $75000.0 (up 111.05% YoY), while the FY2025 annual figure was -$161000.0, up 77.07% from the prior year.
- Other Working Capital Changes declined to $139000.0 in Q1 2026 per HBIO's latest filing, from $478000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $960000.0 in Q2 2023 and bottomed at -$1.7 million in Q3 2024.
- Historically, Other Working Capital Changes has averaged -$288000.0 across 5 years, with a median of -$29000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 988.57% — and 2023, when it surged 347.0%.
- Harvard Bioscience's Other Working Capital Changes stood at -$345000.0 in 2022, then jumped by 245.8% to $503000.0 in 2023, then tumbled by 76.74% to $117000.0 in 2024, then soared by 308.55% to $478000.0 in 2025, then slumped by 70.92% to $139000.0 in 2026.
- Business Quant data shows HBIO's Other Working Capital Changes at $139000.0 in Q1 2026, $478000.0 in Q4 2025, and -$234000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -781,000.00 |
| Jun 30, 2026 | -781,000.00 |
| Jun 30, 2026 | -781,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | -368,000.00 |
| Sep 30, 2025 | -368,000.00 |
| Sep 30, 2025 | -368,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Dec 31, 2024 | -769,000.00 |
| Dec 31, 2024 | -769,000.00 |